Perioperative aspirin safe during robotic partial nephrectomy: Study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-02-08 03:30 GMT   |   Update On 2022-02-08 03:30 GMT
Advertisement

Perioperative aspirin is safe during robotic partial nephrectomy (RPN), according to a new study.However more studies are needed to clarify the role of perioperative aspirin in robotic partial nephrectomy (RPN).

The study has been published in the Journal of Urology.

Daily aspirin use following cardiovascular intervention is commonplace and creates concern regarding bleeding risk in patients undergoing surgery. Despite its cardio-protective role, aspirin is often discontinued 5–7 days prior to major surgery due to bleeding concerns. Single institution studies have investigated perioperative outcomes of aspirin use in robotic partial nephrectomy (RPN). We sought to evaluate the outcomes of perioperative aspirin (pASA) use during RPN in a multicenter setting.

Advertisement

The researchers performed a retrospective evaluation of patients undergoing RPN at 5 high volume RPN institutions. We compared perioperative outcomes of patients taking perioperative aspirin (pASA) (81 mg) to those, not on aspirin. They analyzed the association between perioperative aspirin (pASA) use and perioperative transfusion.

The Results of the study are:

Of 1,565 patients undergoing RPN, 228 (14.5%) patients continued perioperative aspirin (pASA) and were older (62.8 vs 56.8 years, p <0.001) with higher Charlson scores (mean 3 vs 2, p <0.001). Pperioperative aspirin (pASA) was associated with increased perioperative blood transfusions (11% vs 4%, p <0.001) and major complications (10% vs 3%, p <0.001). On multivariable analysis, perioperative aspirin (pASA) was associated with increased transfusion risk (OR 1.94, 1.10–3.45, 95% CI).

Thus, the researchers concluded that in experienced hands, perioperative aspirin 81 mg use during RPN is reasonable and safe; however, there is a higher risk of blood transfusions and major complications. Future studies are needed to clarify the role of antiplatelet therapy in RPN patients requiring perioperative aspirin (pASA) for primary or secondary prevention of cardiovascular events.

Reference:

Perioperative Aspirin Use Is Associated with Bleeding Complications during Robotic Partial Nephrectomy by Joan C. Delto et al. published in the Journal of Urology.

https://www.auajournals.org/doi/10.1097/JU.0000000000002240


Tags:    
Article Source : Journal of Urology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News